Answers are grounded in this paper and cite their sources.
Fundamentally new approaches to birth control--for example, a male pill, a once-a-month menses inducer, and an antifertility vaccine--cannot be realized before the next century, and then only if the virtual withdrawal of the pharmaceutical industry from this field can be reversed. Major changes in product liability would be the most significant incentive.
No takes yet. Share an insight, caveat, or question.
Carl Djerassi (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: